![Shannon Kelley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 6 M $ al 31/08/2026
Shannon Kelley currently works at Madrigal Pharmaceuticals, Inc., as Secretary, Chief Legal Counsel & Executive VP from 2024.
Ms. Kelley also formerly worked at Genzyme Corp., as Chief Compliance Officer-North America.
Ms. Kelley received her graduate degree from American University Washington College of Law and undergraduate degree from Edmund A. Walsh School of Foreign Service.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/08/2026 | 11.474 ( 0,05 % ) | 6 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Consejero General | 05/08/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Oficial de Cumplimiento | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Edmund A. Walsh School of Foreign Service
 Edmund A. Walsh School of Foreign Service Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American University Washington College of Law
 American University Washington College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madrigal Pharmaceuticals, Inc.
 Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
